Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia by Karamitros, D, Morrison, H, Kinstrie, R, Goardon, N, Clark, R, Copland, M, Vyas, P

Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK by Cross, N, White, H, Evans, P, Hancock, J, Copland, M, Milojkovic, D, Mason, J, Craine, S, Mead, A

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia by Kinstrie, R, Karamitros, D, Goardon, N, Morrison, H, Hamblin, M, Robinson, L, Clark, R, Copland, M, Vyas, P

Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemia. by Eyre, T, Schwab, C, Kinstrie, R, McGuire, A, Strefford, J, Peniket, A, Mead, A, Littlewood, T, Holyoake, T, Copland, M, Moorman, A, Harrison, C, Vyas, P

BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients by Kizilors, A, Jackson, S, Anwar, J, Sa, I, Ficinski, L, Mian, S, Best, S, Copland, M, Hassan, S, Mead, A, Ewing, J, Drummond, M, Papanikolaou, M, Ottmann, O, Thompson, M, Lea, N, De Lavallade, H

A randomised evaluation of low-dose cytosine arabinoside (ara-C) plus tosedostat versus low-dose ara-C in older patients with acute myeloid leukaemia: results of the LI-1 trial by Dennis, M, Burnett, A, Hills, R, Thomas, I, Ariti, C, Severinsen, MT, Hemmaway, C, Greaves, P, Clark, RE, Copland, M, Russell, N, National Cancer Research Institute (NCRI) acute myeloid leukaemia (AML) Working Group